Prospective, randomized study to assess the role of dexmedetomidine in patients with supratentorial tumors undergoing craniotomy under general anaesthesia

Middle East Journal of Anesthesiology

Volumn 21, Issue 3, 2011, Pages 325-334

  Soliman, Rabie Nasr ^a   Hassan, Amira Refaie ^a   Rashwan, Amr Madih ^a   Omar, Ahmed Mohamed ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Craniotomy; Dexmedetomidine; Fentanyl; Intracranial pressure; Neurosurgical intensive care unit; Sevoflurane; Supratentorial tumors

Indexed keywords

CARBON DIOXIDE; DEXMEDETOMIDINE; HYPNOTIC SEDATIVE AGENT;

ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; BRAIN TUMOR; CENTRAL VENOUS PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRANIOTOMY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GENERAL ANESTHESIA; GLASGOW COMA SCALE; HEART RATE; HUMAN; INTRACRANIAL PRESSURE; INTRAOPERATIVE PERIOD; MALE; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; PREMEDICATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANESTHESIA, GENERAL; BLOOD PRESSURE; CARBON DIOXIDE; CENTRAL VENOUS PRESSURE; CRANIOTOMY; DEXMEDETOMIDINE; DOUBLE-BLIND METHOD; FEMALE; GLASGOW COMA SCALE; HEART RATE; HUMANS; HYPNOTICS AND SEDATIVES; INTRACRANIAL PRESSURE; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; PAIN, POSTOPERATIVE; POSTOPERATIVE NAUSEA AND VOMITING; PREANESTHETIC MEDICATION; PROSPECTIVE STUDIES; SUPRATENTORIAL NEOPLASMS;

EID: 84859503884     PISSN: 05440440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Basali A, Mascha E, Kalfas I, Schubert A: Relation between perioperative hypertension and intracranial hemorrhage after craniotomy. Anesthesiology; 2000, 93:48-54.
2. Kamibayashi T, Maze M: Clinical uses of α 2-adrenergic agonists. Anesthesiology; 2000, 93:1345-1349.
3. Khan ZP, Ferguson CN, Jones RM: α2 and imidazoline receptor agonists: Their pharmacology and therapeutic role. Anaesthesia; 1999, 54:146-165.
4. Chadha R, Padmanabhan V, Joseph A, Mohandas K: Oral clonidine pretreatment for hemodynamic stability during craniotomy. Anaesth Intensive Care; 1992, 20:341-344.
5. Favre JB, Gardaz JP, Ravussin P: Effect of clonidine on ICP and on the hemodynamic responses to nociceptive stimuli in patients with brain tumors. J Neurosurg Anesthesiol; 1995, 7:159-167.
6. Traill R, Gillis R: Clonidine premedication for craniotomy. Effects on blood pressure and thiopentone dosage. J Neurosurg Anesthiol; 1993, 5:171-177.
7. Calzada BC, De Artinano AA: α2-Adrenoreceptor subtypes. Pharmacolog Res; 2001, 44:195-208.
8. Scheinin M, Pihlavisis M: Molecular pharmacology of α2- adrenoreceptor agonists, in Scholz J, Tonner PH (eds): Bailliere's Best Practice and Research: Clinical Anesthesiology α2- Adrenoreceptor Agonists in Anesthesia and Intensive Care. London, Bailliere Tindall, 2000, pp. 247-260.
9. Hodgson PS, Liu SS: New developments in spinal anesthesia. Anesthesiol Clin North America; 2000, 18:235-249.
10. Coursin DB, Coursin DB, Macciolo GA: Dexmedetomidine. Current Opinion in Critical Care; 2001, 7:221-226.
11. Maze M, Scarfini C, Cavaliere F: New agents for sedation in the intensive care unit. Crit Care Clin; 2001, 17:881-897.
12. Bekker AY, Kaufman B, Samir H, Doyle W: The use of dexmedetomidine infusion for awake craniotomy. Anesth Analg; 2001, 92:1251-1253.
13. Mack PF, Perrine K, Kobylarz E, Schwartz TH, Lien CA: Dexmedetomidine and neurocognitive testing in awake craniotomy. J Neurosurg Anesthesiol; 2004, 16:20-25.
14. Ulrich K, Kuschinsky W: In vivo analysis of alpha-adrenoceptors in pial veins of cats. Acta Physiol Scand Suppl; 1986, 552:37-40.
15. Ma D, Hossain M, Rajakumaraswamy N, Arshad M, Sanders RD, Franks NP, Maze M: Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. Eur J Pharmacol; 2004, 502:87-97.
16. McPherson RW, Brian JE, Traystman RJ: Cerebrovascular responsiveness to carbon dioxide in dogs with 1.4% and 2.8% isoflurane. Anesthesiology; 1989, 70:843-50.
17. Hall JE, Uhrich TD, Barney JA, Shahbaz RA, Ebert TJ: Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg; 2000, 90:699-705.
18. Scheinin B, Lindgren L, Randell T, Scheinin H, Scheinin M: Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and peroperative fentanyl. Br J Anaesth; 1992, 68:126-31.
19. Belleville JP, Ward DS, Bloor BC: Effects of intravenous dexmedetomidine in humans. Sedation, ventilation, and metabolic rate. Anesthesiology; 1992, 77:1125-33.
20. Aho M, Erkola O, Kallio A, Scheinin H, Korttila K: Dexmedetomidine infusion for maintenance of anesthesia in patients undergoing abdominal hysterectomy. Anesth Analg; 1992, 75:940-6.
21. Aantaa R, Jaakola ML, Kallio A, Kanto J: Reduction of the minimum alveolar concentration of isoflurane by dexmedetomidine. Anesthesiology; 1997, 86:1055-60.
22. Khan ZP, Munday IT, Jones RM, Thornton C, Mant TG, Amin D: Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 1: Pharmacodynamic and pharmacokinetic interactions. Br J Anaesth; 1999, 83:372-80.
23. Chadha R, Padmanabhan V, Joseph A, Mohandas K: Oral clonidine pretreatment for haemodynamic stability during craniotomy. Anaesth Intensive Care; 1992, 20:341-4.
24. Costello TG, Cormack JR: Clonidine premedication decreases hemodynamic responses to pin head-holder application during craniotomy. Anesth Analg; 1998, 86:1001-4.
25. Scheinin B, Lindgren L, Randell T, Scheinin H, Scheinin M: Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and peroperative fentanyl. Br J Anaesth; 1992, 68:126-31.
26. Aho M, Erkola O, Kallio A, Scheinin H, Korttila K: Dexmedetomidine infusion for maintenance of anesthesia in patients undergoing abdominal hysterectomy. Anesth Analg; 1992, 75:940-6.
27. Lawrence CJ, De Lange S: Effects of a single preoperative dexmedetomidine dose on isoflurane requirements and perioperative haemodynamic stability. Anaesthesia; 1997, 52:736-44.
28. Lawrence CJ, De Lange S: Effects of a single preoperative dexmedetomidine dose on isoflurane requirements and perioperative haemodynamic stability. Anaesthesia; 1997, 52:736-44.
29. Talke P, Chen R, Thomas B et al: The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg; 2000, 90:834-9.
30. Takenaka M, Iida H, Iida M, Dohi S: Intrathecal dexmedetomidine attenuates hypercapnic but not hypoxic cerebral vasodilation in anesthetized rabbits. Anesthesiology; 2000, 92:1376-84.
31. Ulrich K, Kuschinsky W: In vivo effects of α2-adrenoreceptor agonists and antagonists on pial veins of cats. Stroke; 1985, 16:880-884.
32. Hsu YW, Cortinez LI, Robertson KM et al: Dexmedetomidine pharmacodynamics: Part 1: Crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology; 2004, 101:1066-76.
33. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD: The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology; 2000, 93:382-94.
34. Hall JE, Uhrich TD, Barney JA, Shahbaz RA, Ebert TJ: Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg; 2000, 90:699-705.
35. Shehabi Y, Ruettimann U, Adamson H, Innes R, Ickeringill M: Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects. Intensive Care Med; 2004, 30:2188-96.
36. Arain SR, Ruehlow RM, Uhrich TD, Ebert TJ: The efficacy of dexmedetomidine versus morphine for postoperative nalgesia after major inpatient surgery. Anesth Analg; 2004, 98:153-158.
37. Venn RM, Bradshaw CJ, Spencer R, Brealey D, Caudwell E, Naughton C, Vedio A, Singer M, Feneck R, Treacher D, Willatts SM, Grounds RM: Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia; 1999, 54:1136-1142.
38. Scott F. Thomas Hebert, Randy Cook, Pamela K., McPherson, R: Jack Cassingham, Intraoperative Dexmedetomidine Administration Reduces Postoperative Nausea and Vomiting. American Society Of Anesthesiologists; October 2007, 13-17.
39. Xu H, Aibiki M, Seki K, Ogura S, Ogli K: Effects of dexmedetomidine, an α2- adrenoceptor agonist, on renal sympathetic nerve activity, blood pressure, heart rate and central venous pressure in urethaneanesthetized rabbits. J Auton Nerv Syst; 1998, 72:48-54.
40. Gellai M: Modulation of vasopressin antidiuretic action by renal α 2 -receptors. Am J Physiol; 1990, 259:F1-F8.
41. Menegaz RG, Kapusta DR, Mauad H, de Melo Cabral A: Activation of α2- adrenoreceptors in the rostral ventrolateral medulla evokes natriuresis by arenal nerve mechanism. Am J Physiol; 2001, 218:R98-R101.